In calendar year 2023, 340B covered entities purchased $66.3 billion in covered outpatient drugs under the 340B Program. The program enables safety-net providers to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services for the communities that they serve. The information below details the aggregate 340B purchases by covered entity type in 2023.| www.hrsa.gov
Learn about the Health Resources and Services Administration (HRSA). Read about our programs, find health care, be an organ donor, poison-proof your home, and more.| www.hrsa.gov
HRSA aims to maximize oversight reach and manage compliance risks via program integrity checks, annual recertification, and a self-disclosure process that allows entities to correct their 340B Program.| www.hrsa.gov
Criteria to demonstrate a covered injury occurred, including what is a covered injury and the information needed to file a claim under HRSA’s CICP.| www.hrsa.gov
Johnson & Johnson| www.hrsa.gov
The National Childhood Vaccine Injury Act of 1986 (PDF - 312 KB), as amended, created the National Vaccine Injury Compensation Program (VICP), a no-fault alternative to the traditional tort system. It provides compensation to people found to be injured by certain vaccines. Even in cases in which such a finding is not made, petitioners may receive compensation through a settlement.| www.hrsa.gov
HRSA’s Countermeasures Injury Compensation Program (CICP) was created to provide compensation for serious injuries due to certain countermeasures.| www.hrsa.gov
Vaccines save lives by preventing disease.| www.hrsa.gov
HRSA’s CICP aggregate data for countermeasure injury claims for fiscal years 2010 – 2025.| www.hrsa.gov